William Blair & Company’s VanEck Biotech ETF BBH Stock Holding History

William Blair & Company’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$45.7K	Hold	225	–	–	﹤0.01%	1781
2026 Q1	$42.3K	Hold	225	–	–	﹤0.01%	1713
2025 Q4	$42.6K	Hold	225	–	–	﹤0.01%	1672
2025 Q3	$37.3K	Sell	225 -200	-47%	-$32.6K	﹤0.01%	1673
2025 Q2	$65.1K	Hold	425	–	–	﹤0.01%	1572
2025 Q1	$66.9K	Hold	425	–	–	﹤0.01%	1551
2024 Q4	$66.7K	Hold	425	–	–	﹤0.01%	1572
2024 Q3	$75.4K	Hold	425	–	–	﹤0.01%	1576
2024 Q2	$71.6K	Hold	425	–	–	﹤0.01%	1556
2024 Q1	$70.7K	Hold	425	–	–	﹤0.01%	1558
2023 Q4	$70.3K	Hold	425	–	–	﹤0.01%	1549
2023 Q3	$66.2K	Hold	425	–	–	﹤0.01%	1557
2023 Q2	$66.3K	Hold	425	–	–	﹤0.01%	1557
2023 Q1	$68.9K	Hold	425	–	–	﹤0.01%	1545
2022 Q4	$67.9K	Hold	425	–	–	﹤0.01%	1537
2022 Q3	$60K	Hold	425	–	–	﹤0.01%	1574
2022 Q2	$62K	Hold	425	–	–	﹤0.01%	1601
2022 Q1	$69K	Sell	425 -8	-2%	-$1.3K	﹤0.01%	1668
2021 Q4	$82K	Sell	433 -400	-48%	-$77.1K	﹤0.01%	1716
2021 Q3	$168K	Buy	833 +8	+1%	+$1.68K	﹤0.01%	1534
2021 Q2	$166K	Hold	825	–	–	﹤0.01%	1537
2021 Q1	$145K	Buy	825 +150	+22%	+$27.1K	﹤0.01%	1540
2020 Q4	$115K	Buy	675 +225	+50%	+$37.1K	﹤0.01%	1531
2020 Q3	$73K	Sell	450 -200	-31%	-$32.5K	﹤0.01%	1463
2020 Q2	$106K	Buy	650 +159	+32%	+$24.2K	﹤0.01%	1361
2020 Q1	$63K	Hold	491	–	–	﹤0.01%	1365
2019 Q4	$68K	Buy	491 +50	+11%	+$6.57K	﹤0.01%	1458
2019 Q3	$52K	Hold	441	–	–	﹤0.01%	1452
2019 Q2	$57K	Hold	441	–	–	﹤0.01%	1482
2019 Q1	$57K	Buy	441 +41	+10%	+$5.18K	﹤0.01%	1452
2018 Q4	$44K	Sell	400 -500	-56%	-$60.4K	﹤0.01%	1406
2018 Q3	$122K	Hold	900	–	–	﹤0.01%	1362
2018 Q2	$108K	Hold	900	–	–	﹤0.01%	1336
2018 Q1	$108K	Buy	+900	New	+$113K	﹤0.01%	1263

Other funds holding BBH

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

MIM

Miller Investment Management West Conshohocken, Pennsylvania $1.09B AUM 18.31% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

CCA

Conservest Capital Advisors Wynnewood, Pennsylvania $1.26B AUM 24.75% 1-Year Est. Return

BFG

Bleakley Financial Group Fairfield, New Jersey $7.85B AUM 31.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

William Blair & Company's BBH Position: Q2 2026 in Review

William Blair & Company held its VanEck Biotech ETF (BBH) position steady in Q2 2026 at 225 shares worth $45.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1781.

William Blair & Company first reported a position in BBH in Q1 2018 and has held it in 34 quarters since. The position peaked at $168K in Q3 2021. 110 funds tracked by Wall St. Rank hold BBH as of Q2 2026.

William Blair & Company held 225 shares of VanEck Biotech ETF worth $45.7K as of Q2 2026.
William Blair & Company left its VanEck Biotech ETF share count unchanged in Q2 2026.
VanEck Biotech ETF made up ﹤0.01% of William Blair & Company's portfolio in Q2 2026, its #1781 holding.
William Blair & Company first reported a position in VanEck Biotech ETF in Q1 2018 and has held it in 34 quarters since.
William Blair & Company's VanEck Biotech ETF position peaked at $168K in Q3 2021.
110 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q2 2026.

Based on William Blair & Company's 13F filing for Q2 2026, filed 11 Aug 2026.